Skip to main content
Premium Trial:

Request an Annual Quote

Galileo Genomics Quebec Linkage Disequilibrium Map and DNA Research Innovations CST RNA Purification Kit

Premium

Galileo Genomics has launched its Quebec Linkage Disequilibrium Map, an 80,700-SNP panel covering 99.8 percent of the genome at a density “optimized” for the Quebec French Canadian Founder Population, the company said this week. The QLDM is based on the first complete genome-wide evaluation of genetic sharing, the firm added.


DNA Research Innovations this week launched two products based on its “ChargeSwitch” RNA purification technology, a CST RNA Purification Kit used with cells and a second CST kit for purification from micro-tissue samples, the company said this week. The kits are “10 times as sensitive” as silica methodologies and are intended for analysis of small molecular-weight and rare transcripts, said the company.

Filed under

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.